Welly Nutrition Profile
Key Indicators
- Authorised Capital ₹ 2.00 Cr
as on 16-06-2024
- Paid Up Capital ₹ 0.42 M
as on 16-06-2024
- Company Age 4 Year, 6 Months
- Last Filing with ROC 31 Mar 2023
- Revenue -63.07%
(FY 2023)
- Profit -31.63%
(FY 2023)
- Ebitda -36.57%
(FY 2023)
- Net Worth -27.32%
(FY 2023)
- Total Assets -69.67%
(FY 2023)
About Welly Nutrition
The Company is engaged in the Pharma Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2023. It's a company limited by shares with an authorized capital of Rs 2.00 Cr and a paid-up capital of Rs 0.42 M, as per Ministry of Corporate Affairs (MCA) records.
Sanjeev Kumar, Prasad Vanga, and Sigatapu Sailesh serve as directors at the Company.
- CIN/LLPIN
U74999DL2020PTC363919
- Company No.
363919
- Company Classification
Private Limited Indian Non-Government Company
- Incorporation Date
23 May 2020
- Date of AGM
27 Sep 2023
- Date of Balance Sheet
31 Mar 2023
- Listing Status
Unlisted
- ROC Code
Roc Delhi
Industry
Company Details
- Location
Delhi, Delhi, India
- Telephone
- Email Address
- Website
- Social Media
What products or services does Welly Nutrition Private Limited offer?
Welly Nutrition Private Limited offers a wide range of products and services, including Cns Medication, Melatonin.
Who are the key members and board of directors at Welly Nutrition?
Board Members(3)
Name | Designation | Appointment Date | Status |
---|---|---|---|
Prasad Vanga | Director | 16-Feb-2024 | Current |
Sanjeev Kumar | Director | 30-Mar-2024 | Current |
Sigatapu Sailesh | Director | Current |
Financial Performance and Corporate Structure Insights of Welly Nutrition.
Welly Nutrition Private Limited, for the financial year ended 2023, experienced significant reduction in revenue, with a 63.07% decrease. The company also saw a substantial fall in profitability, with a 31.63% decrease in profit. The company's net worth observed a substantial decline by a decrease of 27.32%.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
Metric |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
---|---|---|---|---|---|---|---|
Total Revenue |
| ||||||
Revenue from Operations |
| ||||||
Total Assets |
| ||||||
Profit or Loss |
| ||||||
Net Worth |
| ||||||
EBITDA |
|
What is the Ownership and Shareholding Structure of Welly Nutrition?
In 2023, Welly Nutrition had a promoter holding of 98.78% and a public holding of 1.22%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
Related Corporates (Common Directorship)
- Anthill Properties Private LimitedActive 4 years 4 months
Prasad Vanga and Sigatapu Sailesh are mutual person
- Anthill Studio Private LimitedActive 5 years 11 months
Prasad Vanga and Sigatapu Sailesh are mutual person
- Anthill Venture Capital Advisors LlpActive 6 years 9 months
Prasad Vanga and Sigatapu Sailesh are mutual person
Charges (Loans)
There are no open charges registered against the company as per our records.
How Many Employees Work at Welly Nutrition?
Unlock and access historical data on people associated with Welly Nutrition, such as employment history, contributions to the Employees' Provident Fund Organization (EPFO), and related information.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Welly Nutrition, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Welly Nutrition's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.